NFE2L2 and non-small cell lung carcinoma: Trabectedin has been reported to upregulate iron, ROS, and lipid peroxidation by enhancing the HIF-1α/IRP1/TFR1 axis and inhibiting the KEAP1/NRF2/GPX4 pathway, leading to ferroptosis in NSCLC cells [35].